Efficacy and Safety of Intracameral Versus Intravitreal Bevacizumab Injection as an Adjunctive Therapy Before Trabeculectomy With Mitomycin-C in Neovascular Glaucoma: A Prospective Randomized Trial
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To prospect studying the efficacy and safety of treating NVG with the intracameral versus the intravitreal injection of Bevacizumab.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of neovascular glaucoma
• The patients having IOP \> 21 mmHg, having the indication for trabeculectomy
• The patients' age of at least 18-year-old
• The patients having visual potential at least hand motion.
• Present of NVI or NVA.
• Willing and able to provide informed consent to participate in the study
• Able to understand the purpose of the study, his/her role, and is available to return to the clinic/hospital for all required follow-up visits
Locations
Other Locations
Thailand
Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University
RECRUITING
Hat Yai
Contact Information
Primary
Assoc.Prof.Weerawat Kiddee, MD
kweerawat@hotmail.com
+66874954626
Time Frame
Start Date: 2018-08-01
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 40
Treatments
Experimental: Intracameral injection
Intracameral Bevacizumab 1.25 mg/0.05 mL. Injection
Experimental: Intravitreal injection
Intravitreal Bevacizumab 1.25 mg/0.05 mL. Injection
Related Therapeutic Areas
Sponsors
Leads: Prince of Songkla University